News Release

Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9


EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it will report its financial results for the first quarter ended March 31, 2018, after the market close, and will host a corporate update conference call and webcast on Wednesday, May 9, 2018, at 4:30 PM Eastern Time.

Conference Call Details
Wednesday, May 9th @ 4:30pm Eastern Time/1:30pm Pacific Time

Toll Free: 866-548-4713
International: 323-794-2093
Conference ID: 7186111
Replays, available through May 23rd
Domestic: 844-512-2921
International: 412-317-6671
Replay PIN: 7186111

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.

For more information, visit

Andrew McDonald
Founding Partner, LifeSci Advisors LLC

Primary Logo

Source: Zogenix, Inc.